Anti-Nicotinic Acetylcholine Receptor beta/CHRNB1 antibody [EP2067Y]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Rabbit Recombinant Monoclonal Nicotinic Acetylcholine Receptor beta/CHRNB1 antibody. Suitable for WB and reacts with Human, Rat, Mouse samples. Cited in 2 publications.
View Alternative Names
ACHRB, CHRNB, CHRNB1, Acetylcholine receptor subunit beta
- WB
Unknown
Western blot - Anti-Nicotinic Acetylcholine Receptor beta/CHRNB1 antibody [EP2067Y] (AB76159)
All lanes:
Western blot - Anti-Nicotinic Acetylcholine Receptor beta/CHRNB1 antibody [EP2067Y] (ab76159) at 1/1000 dilution
All lanes:
Human brain lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit HRP at 1/2000 dilution
Predicted band size: 57 kDa
Observed band size: 57 kDa
false
- WB
Supplier Data
Western blot - Anti-Nicotinic Acetylcholine Receptor beta/CHRNB1 antibody [EP2067Y] (AB76159)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
All lanes:
Western blot - Anti-Nicotinic Acetylcholine Receptor beta/CHRNB1 antibody [EP2067Y] (ab76159) at 1/1000 dilution
All lanes:
Mouse Brain lysate
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG
Predicted band size: 57 kDa
Observed band size: 57 kDa
false
- WB
Supplier Data
Western blot - Anti-Nicotinic Acetylcholine Receptor beta/CHRNB1 antibody [EP2067Y] (AB76159)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
All lanes:
Western blot - Anti-Nicotinic Acetylcholine Receptor beta/CHRNB1 antibody [EP2067Y] (ab76159) at 1/1000 dilution
All lanes:
Rat Brain lysate
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG
Predicted band size: 57 kDa
Observed band size: 57 kDa
false
Related conjugates and formulations (1)
-
Anti-Nicotinic Acetylcholine Receptor beta/CHRNB1 antibody [EP2067Y] - BSA and Azide free
Reactivity data
Product details
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CHRNB1 functions as a component of the pentameric ion channel complex that forms upon binding with other subunits like the alpha subunit of nAChR. When acetylcholine binds to this channel it permits the flow of cations such as sodium and calcium into cells which leads to depolarization and subsequent neurotransmission. This process is fundamental for various neurological functions including muscle contraction and cognitive processes. The receptor is critical for maintaining the efficiency of synaptic connectivity and signaling.
Pathways
CHRNB1 plays a role in neural pathways such as the cholinergic and dopaminergic pathways influencing neurotransmission and behavior. In the cholinergic pathway nAChRs including CHRNB1 modulate the release of other neurotransmitters and are integral to processes like learning and memory. Additionally associations with proteins like CHRNA1 and CHRNA4 illustrate the receptor's involvement in ensuring proper synaptic signaling and response to neurotransmitters across neural circuits.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Neural regeneration research 15:1678-1685 PubMed32209772
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of applied physiology (Bethesda, Md. : 1985) 124:888-898 PubMed29357501
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com